EDGAR Filing Documents for 0001104659-21-006709

Form 8-K - Current report:

SEC Accession No. 0001104659-21-006709

Filing Date

2021-01-22

Accepted

2021-01-22 17:00:13

Documents

Period of Report

2021-01-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm213796d1_8k.htm	8-K	28493
2	EXHIBIT 4.1	tm213796d1_ex4-1.htm	EX-4.1	105479
3	EXHIBIT 4.2	tm213796d1_ex4-2.htm	EX-4.2	100841
4	EXHIBIT 4.3	tm213796d1_ex4-3.htm	EX-4.3	101568
5	EXHIBIT 4.4	tm213796d1_ex4-4.htm	EX-4.4	101017
6	EXHIBIT 10.1	tm213796d1_ex10-1.htm	EX-10.1	222238
7	EXHIBIT 10.2	tm213796d1_ex10-2.htm	EX-10.2	145959
8	EXHIBIT 10.3	tm213796d1_ex10-3.htm	EX-10.3	88776
9	EXHIBIT 10.4	tm213796d1_ex10-4.htm	EX-10.4	116609
10	EXHIBIT 99.1	tm213796d1_ex99-1.htm	EX-99.1	9639
	Complete submission text file	0001104659-21-006709.txt		1021932

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005

Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)